VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report ...

The real risk isn't in running robust tests; it’s in wasting money or cutting high-performing channels based on misleading ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

NEW YORK and NIJMEGEN, Netherlands, Sept. 23, 2025 /PRNewswire/ -- ScreenPoint Medical today announced that its Transpara® ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled "Melatonin agonist ...

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

A total of 295 eligible patients were enrolled with a median follow-up of 5.0 years. The arms were well balanced, with a median age of 65 years (IQR 59-71), 50% with positive surgical margins, 51% ...

Aclarion is betting that its Nociscan technology can reshape how spine surgeons identify pain-generating discs. The company’s pivotal Clarity trial is designed to provide the evidence to make that ...

A large Dutch randomized clinical trial (SUMMER) found that a widely marketed antioxidant supplement (Impryl) did not improve ...